Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03979885 · ClinicalTrials.gov registry record · NA
Financial Incentives for Smoking Treatment II
A NA study, sponsored by University of California, Los Angeles.
- Active
- Registry status
- NA
- Development phase
- 1,058
- Enrollment target
NCT03979885 is a NA study that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 1,058 participants.
The verdict
NCT03979885, a NA study, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,058 participants
- Enrollment target
Study Summary
Financial incentives for motivating changes in health behavior, particularly for smoking and other morbid habits, are increasingly being tested by health insurers, employers, and government agencies. However, in using incentive programs for smoking cessation, key unanswered structural and theoretical questions remain regarding their effectiveness, acceptability to patients, and economic sustainability. This trial aims to advance the science and implementation of financial incentives for smoking cessation interventions among high-risk, hospitalized smokers. The investigators will pursue two specific aims: 1) comparing the impact of three approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life and 2) comparing the short-term and long term return on investment of using goal directed and outcome-based financial incentives to promote smoking cessation.
Interventions
- BEHAVIORAL Smoking cessation counseling (Quitline)
- BEHAVIORAL Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)
- BEHAVIORAL Financial incentives for smoking cessation
- BEHAVIORAL Financial incentives for use of evidence-based smoking cessation therapies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,058 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03979885
The ClinicalTrials.gov registry entry for NCT03979885 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,058 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Smoking cessation counseling (Quitline) is the first listed.
NCT03979885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03979885 about?
NCT03979885 is a clinical study titled "Financial Incentives for Smoking Treatment II". Financial incentives for motivating changes in health behavior, particularly for smoking and other morbid habits, are increasingly being tested by health insurers, employers, and government agencies. However, in using incentive programs for smoking cessation, key unanswered structural and theoretica...
What is the current status of trial NCT03979885?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,058 participants. The study started on 2020-01-06. Estimated completion is 2027-06-30.
What interventions are being tested in trial NCT03979885?
The interventions under investigation include: Smoking cessation counseling (Quitline) (BEHAVIORAL), Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy) (BEHAVIORAL), Financial incentives for smoking cessation (BEHAVIORAL), Financial incentives for use of evidence-based smoking cessation therapies (BEHAVIORAL).
Who is sponsoring clinical trial NCT03979885?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.